A Systematic Review and Meta-analysis on Stenting for Aortic Coarctation Management in Adults

Petroula Nana1, Konstantinos Spanos1,2, Alexandros Brodis3

  • 1Vascular Surgery Department, University Hospital of Larissa, Faculty of Medicine, School of Health Sciences, University of Thessaly, Larissa, Greece.

Insights

Stenting for aortic coarctation (CoA) in adults shows high technical success (97%) with acceptable intra-operative and 30-day mortality rates. Midterm follow-up reveals a low re-intervention rate, demonstrating the safety and effectiveness of this endovascular approach.

Area of Science:

  • Cardiovascular Surgery
  • Interventional Cardiology
  • Medical Devices

Background:

  • Aortic coarctation (CoA) is a congenital heart defect often diagnosed in adulthood, presenting as native or recurrent disease.
  • Previous endovascular treatments like angioplasty have shown high complication and re-intervention rates.
  • Stenting offers a potentially safer and more effective endovascular solution for adult CoA.

Purpose of the Study:

  • To systematically review and meta-analyze the outcomes of endovascular stenting for adult aortic coarctation (CoA).
  • To assess technical success, re-intervention rates, and mortality associated with CoA stenting.
  • To compare stenting outcomes against historical data for other endovascular interventions.

Main Methods:

  • A systematic literature search was conducted across PubMed, EMBASE, and CENTRAL databases up to December 30, 2021.
  • Studies focusing on adult patients with native or recurrent CoA treated with stenting were included.
  • Proportional meta-analysis was used to evaluate technical success, intra-operative complications, 30-day mortality, and midterm re-intervention rates.

Main Results:

  • The meta-analysis included 27 articles with 705 adult patients (65.7% native CoA).
  • Technical success rate was high at 97% (95% CI, 0.96%-0.99%).
  • Intra-operative complications (rupture, dissection) and 30-day mortality were low (1-2%). Midterm re-intervention rate was 8% (95% CI, 0.05%-0.10%), with 95.5% managed endovascularly.

Conclusions:

  • Endovascular stenting for adult aortic coarctation (CoA) demonstrates high technical success and acceptable safety profiles.
  • Intra-operative and 30-day mortality rates are low, with a manageable midterm re-intervention rate.
  • Stenting is a safe and effective endovascular option for adult CoA, though further research on stent types is warranted.
Abstract

Related Concept Videos

Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
26
Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
12
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
14
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
15
Aneurysm II: Clinical Manifestations and Diagnostic Studies01:21

Aneurysm II: Clinical Manifestations and Diagnostic Studies

Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
11
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
11